CLBCORE LABORATORIES N V

NYSE corelab.com


$ 16.95 $ -0.13 (-0.76 %)    

Friday, 26-Apr-2024 15:59:37 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 16.94
$ 17.21
$ 0.00 x 0
$ 0.00 x 0
$ 16.80 - $ 17.52
$ 13.82 - $ 27.90
522,902
na
804.33M
$ 1.19
$ 33.92
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-27-2023 03-31-2023 10-Q
2 02-10-2023 12-31-2022 10-K
3 10-28-2022 09-30-2022 10-Q
4 07-28-2022 06-30-2022 10-Q
5 04-28-2022 03-31-2022 10-Q
6 02-10-2022 12-31-2021 10-K
7 10-28-2021 09-30-2021 10-Q
8 07-30-2021 06-30-2021 10-Q
9 04-23-2021 03-31-2021 10-Q
10 02-08-2021 12-31-2020 10-K
11 10-22-2020 09-30-2020 10-Q
12 07-24-2020 06-30-2020 10-Q
13 04-24-2020 03-31-2020 10-Q
14 02-10-2020 12-31-2019 10-K
15 10-25-2019 09-30-2019 10-Q
16 07-26-2019 06-30-2019 10-Q
17 04-26-2019 03-31-2019 10-Q
18 02-11-2019 12-31-2018 10-K
19 10-25-2018 09-30-2018 10-Q
20 07-27-2018 06-30-2018 10-Q
21 04-27-2018 03-31-2018 10-Q
22 02-12-2018 12-31-2017 10-K
23 10-25-2017 09-30-2017 10-Q
24 07-26-2017 06-30-2017 10-Q
25 04-21-2017 03-31-2017 10-Q
26 02-10-2017 12-31-2016 10-K
27 10-21-2016 09-30-2016 10-Q
28 07-22-2016 06-30-2016 10-Q
29 04-22-2016 03-31-2016 10-Q
30 02-12-2016 12-31-2015 10-K
31 10-23-2015 09-30-2015 10-Q
32 07-27-2015 06-30-2015 10-Q
33 04-29-2015 03-31-2015 10-Q
34 02-17-2015 12-31-2014 10-K
35 11-04-2014 09-30-2014 10-Q
36 07-25-2014 06-30-2014 10-Q
37 04-25-2014 03-31-2014 10-Q
38 02-13-2014 12-31-2013 10-K
39 10-18-2013 09-30-2013 10-Q
40 07-19-2013 06-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-hold-on-core-laboratories-raises-price-target-to-18

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $17 to $18.

 core-laboratories-q1-2024-adj-eps-019-beats-016-estimate-sales-129637m-beat-124442m-estimate

Core Laboratories (NYSE:CLB) reported quarterly Adj earnings of $0.19 per share which beat the analyst consensus estimate of $0...

 b-of-a-securities-maintains-underperform-on-core-laboratories-lowers-price-target-to-16

B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price ta...

 top-cannabis-appointments-you-should-know-about-auroras-new-cfo-and-other-changes

Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of pre...

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-17-report-released-on-4-february-2024

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $21 to $17.

 core-laboratories-q4-adj-eps-019-inline-sales-12821m-beat-12777m-estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is a...

 earnings-scheduled-for-january-31-2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue...

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-21-report-released-on-28-january-2024

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $23 to $21.

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-21

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $23 to $21.

 core-laboratories-q3-2023-adj-eps-022-inline-sales-12534m-miss-12997m-estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a...

 earnings-scheduled-for-november-1-2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of...

 northrop-grumman-general-dynamics-lockheed-martin-and-other-big-stocks-moving-higher-on-monday

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Monday. Here are some big stocks recording gains in to...

 halliburton-and-core-laboratories-collaborate-to-accelerate-digital-rock-data-solutions

Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) announced a strategic alliance aimed at expediting the d...

Core News & Articles

Halliburton Company (NYSE:HAL) and Core Laboratories Inc. (NYSE:CLB) today announced a strategic collaboration in the U.S. to c...

 citigroup-maintains-sell-on-core-laboratories-lowers-price-target-to-20

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $21 to $20.

 piper-sandler-maintains-neutral-on-core-laboratories-raises-price-target-to-21

Piper Sandler analyst Luke Lemoine maintains Core Laboratories (NYSE:CLB) with a Neutral and raises the price target from $1...

 core-laboratories-q2-eps-021-beats-020-estimate-sales-12788m-miss-13146m-estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.20 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION